Researchers have been excited about this new drug, a groundbreaking dual treatment showing significant outcomes in initial trials for weight reduction . It acts by modulating both pathways : GLP-1 and GIP, these, when activated , support influence cravings and enhance metabolism . Preliminary observations demonstrate considerable body loss and pote